I-Mab (IMAB) |
|
39 0.78 (2.04%)
|
09-29 01:33 |
|
Open: |
38.3 |
Pre. Close: |
38.22 |
|
High:
|
39.5099 |
Low:
|
37.8901 |
|
Volume:
|
90,275 |
Market Cap:
|
2,749M |
|
|
|
|
I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 185 full-time employees. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
39.53 - 39.725 |
39.725 - 39.922 |
|
Low:
|
37.44 - 37.639 |
37.639 - 37.84 |
|
Close:
|
38.676 - 38.995 |
38.995 - 39.319 |
|
Technical analysis |
as of: 2020-09-28 4:33:59 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 49.41 One year: 57.71 |
| Support: |
Support1: 34.45  Support2: 29.60 |
| Resistance: |
Resistance1: 42.30 Resistance2: 49.41 |
| Pivot: |
38.51 |
| Moving Average: |
MA(5): 39.56 MA(20): 38.02
MA(100): 29.62 MA(250): |
| MACD: |
MACD(12,26): 1.78  Signal(9): 1.90 |
| Stochastic oscillator: |
%K(14,3): 51.16 %D(3): 64.52 |
| RSI: |
RSI(14): 57.17 |
| 52-week: |
High: 42.30 Low: 9.30 Change(%): 212.0 |
| Average Vol(K): |
3-Month: 15324 10-Days: 17531 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.IMAB has closed below upper band by 40.3%. Bollinger Bands are 30.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sun, 20 Sep 2020
Analysts Are Betting On I-Mab (NASDAQ:IMAB) With A Big Upgrade This Week - Yahoo Finance
Tue, 15 Sep 2020
I-Mab inks multi-billion dollar deal with AbbVie - The Pharma Letter
Wed, 09 Sep 2020
I-Mab (IMAB) Surges: Stock Moves 5.5% Higher - Yahoo Finance
Tue, 08 Sep 2020
I-Mab Announces Upcoming Participation at September Conferences English English - PRNewswire
Tue, 08 Sep 2020
AbbVie I-Mab Cancer Deal, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
Fri, 04 Sep 2020
I-Mab Announces $418 Million Private Placement with Hillhouse Capital-Led Consortium - PRNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
71 |
| Shares Float (M) |
24 |
|
% Held by Insiders
|
0.99 |
|
% Held by Institutions
|
0.92 |
|
Shares Short (K)
|
15 |
|
Shares Short P. Month (K)
|
19 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-39.2 |
|
Return on Equity (ttm)
|
-74.3 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
0.426 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
|
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
